Response-adapted lenalidomide maintenance in newly diagnosed myeloma: results from the phase III GMMG-MM5 trial

Hartmut Goldschmidt, K. Elias, Jan Dürig, Christof Scheid, Katja Weisel, Christina Kunz, Uta Bertsch, Thomas Hielscher, Maximilian Merz, Markus Munder, Hans‐Walter Lindemann, Barbara Hügle-Dörr, Diana Tichy, Nicola Giesen, Dirk Hose, Anja Seckinger, Stefanie Huhn, Steffen Luntz, Anna Jauch, Ahmet Elmaağaclı, Bernhard Rabold, Stephan Fuhrmann, Peter Brossart, Martin Göerner, Helga Bernhard, Martin Hoffmann, Jens Hillengaß, Marc S. Raab, Igor Wolfgang Blau, Mathias Hänel, Hans Salwender